BRIEF published on 05/16/2024 at 22:35, 2 years 2 months ago DBV Technologies announces the results of the 2024 Combined General Meeting General Assembly 2024 DBV Technologies Resolutions Adopted Allergy Treatment Biopharmaceutical Sector
PRESS RELEASE published on 05/16/2024 at 22:30, 2 years 2 months ago DBV Technologies Announces Results of its 2024 Combined General Meeting DBV Technologies announces successful results of its 2024 Combined General Meeting where shareholders approved all proposed resolutions. The Company focuses on treatment options for food allergies Resolutions Combined General Meeting DBV Technologies Food Allergies Treatment Options
BRIEF published on 05/09/2024 at 22:35, 2 years 2 months ago DBV Technologies announces its participation in two investor conferences in May DBV Technologies Food Allergy JMP Life Sciences HC Wainwright BioConnect Conference Webcast
PRESS RELEASE published on 05/09/2024 at 22:30, 2 years 2 months ago DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies to participate in two upcoming investor conferences in May, presenting its clinical-stage biopharmaceutical developments. Learn more about their innovative treatment options Investor Conferences Biopharmaceutical DBV Technologies Food Allergies Immunologic Conditions
BRIEF published on 05/07/2024 at 22:35, 2 years 2 months ago DBV Technologies publishes its financial results for the first quarter of 2024 and provides an update on its activities DBV Technologies Financial Results Effectiveness Viaskin Peanut Regulatory Affairs Appointment Cash Flow Evolution VITESSE Clinical Trial
PRESS RELEASE published on 05/07/2024 at 22:30, 2 years 2 months ago DBV Technologies Reports First Quarter 2024 Financial Results and Business Update DBV Technologies reports Q1 2024 financial results and business update, with VITESSE enrollment progress, appointment of Chief Regulatory Officer, and $101.5 million cash balance Financial Results Q1 2024 DBV Technologies VITESSE Enrollment Chief Regulatory Officer
Published on 08/06/2026 at 14:30, 37 minutes ago Loar Holdings Inc. Reports Q2 2026 Record Results and Upward Revision to 2026 Outlook
Published on 08/06/2026 at 14:30, 37 minutes ago NV Gold Announces Expansion of Holdings and Drill Program at the Slumber Gold Project in Nevada
Published on 08/06/2026 at 14:30, 37 minutes ago AIAI Holdings' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare
Published on 08/06/2026 at 14:00, 1 hour 7 minutes ago Adcore to Publish Second Quarter 2026 Results on August 13, 2026
Published on 08/06/2026 at 14:00, 1 hour 7 minutes ago Aeonian Reports Final Drill Results from Jake Target and Advances District-Scale Copper Exploration Model at Koocanusa
Published on 08/06/2026 at 14:40, 27 minutes ago Acceptance Period Commences: Persistent Publishes Public Takeover Offer for all Nagarro Shares
Published on 08/06/2026 at 14:35, 32 minutes ago Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $378 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens
Published on 08/06/2026 at 14:01, 1 hour 6 minutes ago Original-Research: DEUTZ AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 08/06/2026 at 08:00, 7 hours 7 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/05/2026 at 18:00, 21 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 21 hours 17 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 21 hours 22 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 21 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
